ARCHIVES

Clinical Cooperative Groups Asked To Develop Tamoxifen Prevention Trial; CGOPs To Participate

This article is from The Cancer Letter archive.

Vol. 16 No. 27 | July 6, 1990

Download PDF Visit The Full Archive

Related Articles

Arzerra Maintenance Therapy Extends PFS In Phase III Trial, Compared to Observation

August 29, 2014

Creating the Modern Cancer Center

November 2, 2021

Women’s Health Initiative Trial Produced $37.1 Billion in Returns

May 9, 2014

Scientists, Industry Identify Barriers To Development of Molecular Therapies

April 12, 2002

NCAB Committee Seeks Organ Systems Upgrade

February 7, 1986

UC Davis Becomes 41st Center to Earn NCI Comprehensive Designation

March 16, 2012